Perinatal management of fetal congenital heart disease in the era of COVID-19.

Masuda, Hitomi; Inuzuka, Ryo; Toshimitsu, Masatake; Kashima, Kohei; Matsui, Hikoro

Masuda, Hitomi; Inuzuka, Ryo; Toshimitsu, Masatake; Kashima, Kohei; Matsui, Hikoro.

Masuda H; Department of Pediatrics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Inuzuka R; Department of Pediatrics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Toshimitsu M; Department of Obstetrics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Kashima K; Department of Pediatrics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Matsui H; Department of Pediatrics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Pediatr Int ; 64(1): e14932, 2022 01.

Article in English | MEDLINE | ID: covidwho-1673264

Subject(s)

COVID-19; Heart Defects, Congenital; Female; Fetus; Heart Defects, Congenital/therapy; Humans; Pregnancy; SARS-CoV-2; Ultrasonography, Prenatal

Keywords

COVID-19; congenital heart disease; fetal diagnosis; informed consent; precaution

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Heart Defects, Congenital Limits: Female / Humans / Pregnancy Language: English Journal: Pediatr Int Journal subject: Pediatrics Year: 2022 Document Type: Article Affiliation country: Ped.14932

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google